血小板的全球市場 (2022年~2030年):市場規模 (各血小板、用途、終端用戶)、各地區展望、成長性、價格趨勢、競爭市場佔有率、預測
市場調查報告書
商品編碼
1147387

血小板的全球市場 (2022年~2030年):市場規模 (各血小板、用途、終端用戶)、各地區展望、成長性、價格趨勢、競爭市場佔有率、預測

Blood Platelets Market Size By Platelet, By Application, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2030

出版日期: | 出版商: Global Market Insights Inc. | 英文 179 Pages | 商品交期: 2-3個工作天內

價格

全球血小板的市場,預計至2030年記錄相當的成長。

產業的成長,起因於血友病的病例數的增加血小板輸血的需求增加。因為患者的安全標準不斷進化,促進併發症少的血液療法的實現,形成產業的展望。

本報告提供全球血小板的市場調查,市場概要,市場成長的各種影響因素分析,法律規章、償付環境,技術形勢,市場規模的變化、預測,各種區分、各地區/主要國家的明細,競爭環境,主要企業簡介等彙整資訊。

目錄

第1章 調查手法、調查範圍

第2章 摘要整理

第3章 血小板產業的考察

  • 產業的分類
  • 產業形勢
  • 產業的影響要素
    • 促進因素
    • 潛在的風險&課題
  • 成長性分析
  • COVID-19:影響分析
  • 價格分析
  • 法規情形
  • 償付情境
  • 差距分析
  • 技術形勢
  • 波特分析
  • 競爭情形
  • 大環境分析

第4章 血小板市場:血小板各類型

  • 主要趨勢
  • 全血來源血小板
  • a單採術來源血小板

第5章 血小板市場:各產品

  • 主要趨勢
  • 血友病
  • 血小板減少性疾病
  • 手術全期適應症
  • 血小板功能障礙
  • 血液腫瘤
  • 其他

第6章 血小板市場:各終端用戶

  • 主要趨勢
  • 醫院
  • 門診病人手術中心
  • 其他

第7章 血小板市場:各地區

  • 主要趨勢
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第8章 企業簡介

  • 策略儀表板
  • America's Blood Centers
  • The American National Red Cross
  • American Association of Blood Banks(AABB)
  • Blood Centers of America
  • Brazilian Red Cross
  • Canadian Blood Services
  • The European Blood Alliance
  • French Red Cross
  • German Red Cross
  • Indian Red Cross Society
  • Italian Red Cross
  • Japanese Red Cross
  • Red Cross Society of China
  • OneBlood
  • South African Red Cross Society
  • Spanish Red Cross
Product Code: 2849

The global blood platelets market is anticipated to register considerable gains through 2030. The industry expansion can be credited to the growing demand for platelet transfusions due to the rising cases of hemophilia. The constantly evolving patient safety standards have bolstered the realization for blood therapies that entail fewer complications, which shapes the industry outlook.

To that end, blood banks and healthcare units are increasingly investing in medical advancements to bring safe transfusion systems to their portfolio of services. The presence of government agencies that regulate blood and blood component collection is also shaping the industry scenario.

The high treatment costs associated with blood platelet therapies and awareness around the risk of infection are likely to hold back market revenues. The high associated costs make the treatment inaccessible to patients belonging to low socioeconomic background and low-income countries, which greatly limits the industry scope.

The overall blood platelets market landscape is bifurcated into segments such as platelet, application, end-use, and regional outlook.

Based on platelet, the market is segmented into whole blood derived platelets and apheresis derived platelets. Amongst them, whole blood derived platelets segment is witnessing surging demand owing to the crucial role they play in organ transplant and oncological procedures. WBD platelets are typically derived from four to five whole blood donations and are increasingly used in standard transfusion procedures. The collected platelets are frequently leukoreduced, pooled, and bacterially tested, which increases their usage in healthcare settings.

On the basis of application, the industry is divided into thrombocytopenia, hemophilia, platelet function disorders, perioperative Indications, and hemato-oncology. The market is projected to experience an elevated demand from the platelet function disorders segment, driven by the increasing prevalence of platelet disorders. The bleeding disorders accompanied by such defects increase the need for blood platelets to lessen the severity of the ailments.

Based on end use, the industry is categorized into hospitals and ambulatory centers. The hospital segment is set to gain considerable traction over 2022-2030, owing to increasing advancements in blood, collection, transfusion, and blood-related therapies. The higher level of expertise with respect to donor screening, data automation, and improved transfusion practices, sways patient inclination towards the hospital settings, fostering segment growth. The presence of highly trained staff also works in favor of the segment.

From a regional viewpoint, the market is segmented into North America, the Middle East and Africa, Latin America, Asia Pacific, and Europe. The Asia Pacific segment valuation is poised to surpass USD 1.5 billion owing to the rising presence of blood banks in the region. Their expansion is being driven by increasing investments towards the strengthening of healthcare infrastructure. Additionally, the emergence of NGO sector blood banks in countries like India, Bangladesh, and Pakistan is also anticipated to augment the industry expansion.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definitions
  • 1.2 Base estimates and working
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Blood platelets industry 360 degree synopsis, 2017 - 2030
  • 2.2 Business trends
    • 2.2.1 Platelet type trends
    • 2.2.2 Product trends
    • 2.2.3 End-use trends
    • 2.2.4 Regional trends

Chapter 3 Blood Platelets Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2030 (USD Million)
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing prevalence of chronic and blood-related disorders
      • 3.3.1.2 Growing demand for blood transfusions
      • 3.3.1.3 Rise in awareness regarding blood donations and platelets transfusions
      • 3.3.1.4 Rising number of surgical procedures
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 High risk of transmissions of infections
      • 3.3.2.2 High cost of the treatment
  • 3.4 Growth potential analysis
    • 3.4.1 By platelet type
    • 3.4.2 By application
    • 3.4.3 By end-use
  • 3.5 COVID- 19 impact analysis
  • 3.6 Pricing analysis, 2017-2030
    • 3.6.1 North America
      • 3.6.1.1 U.S.
      • 3.6.1.2 Canada
    • 3.6.2 Europe
      • 3.6.2.1 Germany
      • 3.6.2.2 UK
      • 3.6.2.3 France
      • 3.6.2.4 Spain
      • 3.6.2.5 Italy
    • 3.6.3 Asia Pacific
      • 3.6.3.1 China
      • 3.6.3.2 Japan
      • 3.6.3.3 India
      • 3.6.3.4 Australia
      • 3.6.3.5 South Korea
    • 3.6.4 Latin America
      • 3.6.4.1 Brazil
      • 3.6.4.2 Mexico
      • 3.6.4.3 Argentina
    • 3.6.5 Middle East and Africa
      • 3.6.5.1 South Africa
      • 3.6.5.2 Saudi Arabia
      • 3.6.5.3 UAE
  • 3.7 Regulatory landscape
    • 3.7.1 U.S.
    • 3.7.2 Europe
  • 3.8 Reimbursement scenario
    • 3.8.1 U.S.
  • 3.9 Gap analysis
  • 3.10 Technology landscape
  • 3.11 Porter's Analysis
  • 3.12 Competitive landscape, 2021
    • 3.12.1 Company matrix analysis, 2021
  • 3.13 PESTLE Analysis

Chapter 4 Blood Platelets Market, By Platelet Type

  • 4.1 Key segment trends
  • 4.2 Whole blood derived platelets
    • 4.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 4.3 Apheresis derived platelets
    • 4.3.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 5 Blood Platelets Market, By Product

  • 5.1 Key segment trends
  • 5.2 Hemophilia
    • 5.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.3 Thrombocytopenia
    • 5.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.4 Perioperative indications
    • 5.4.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.5 Platelet function disorders
    • 5.5.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.6 Hemato-oncology
    • 5.6.1 Market size, by region, 2017 - 2030 (USD Million)
  • 5.7 Others
    • 5.7.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 6 Blood Platelets Market, By End-use

  • 6.1 Key segment trends
  • 6.2 Hospitals
    • 6.2.1 Market size, by region, 2017 - 2030 (USD Million)
  • 6.3 Ambulatory surgical centers
    • 6.3.1 Market size, by region, 2017 - 2030 (USD Million)
  • 6.4 Others
    • 6.4.1 Market size, by region, 2017 - 2030 (USD Million)

Chapter 7 Blood Platelets Market, By Region

  • 7.1 Key regional trends
  • 7.2 North America
    • 7.2.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.2.2 Market size, by platelet type, 2017 - 2030 (USD Million)
    • 7.2.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.2.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.2.5 U.S.
      • 7.2.5.1 Market size, by platelet type, 2017 - 2030 (USD Million)
      • 7.2.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.2.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.2.6 Canada
      • 7.2.6.1 Market size, by platelet type, 2017 - 2030 (USD Million)
      • 7.2.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.2.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.3.2 Market size, by platelet type, 2017 - 2030 (USD Million)
    • 7.3.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.3.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.5 Germany
      • 7.3.5.1 Market size, by platelet type, 2017 - 2030 (USD Million)
      • 7.3.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.6 UK
      • 7.3.6.1 Market size, by platelet type, 2017 - 2030 (USD Million)
      • 7.3.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.7 France
      • 7.3.7.1 Market size, by platelet type, 2017 - 2030 (USD Million)
      • 7.3.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.8 Spain
      • 7.3.8.1 Market size, by platelet type, 2017 - 2030 (USD Million)
      • 7.3.8.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.3.9 Italy
      • 7.3.9.1 Market size, by platelet type, 2017 - 2030 (USD Million)
      • 7.3.9.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.3.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.4.2 Market size, by platelet type, 2017 - 2030 (USD Million)
    • 7.4.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.4.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.5 China
      • 7.4.5.1 Market size, by platelet type, 2017 - 2030 (USD Million)
      • 7.4.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.6 Japan
      • 7.4.6.1 Market size, by platelet type, 2017 - 2030 (USD Million)
      • 7.4.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.7 India
      • 7.4.7.1 Market size, by platelet type, 2017 - 2030 (USD Million)
      • 7.4.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.8 Australia
      • 7.4.8.1 Market size, by platelet type, 2017 - 2030 (USD Million)
      • 7.4.8.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.8.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.4.9 South Korea
      • 7.4.9.1 Market size, by platelet type, 2017 - 2030 (USD Million)
      • 7.4.9.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.4.9.3 Market size, by end-use, 2017 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.5.2 Market size, by platelet type, 2017 - 2030 (USD Million)
    • 7.5.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.5.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.5.5 Brazil
      • 7.5.5.1 Market size, by platelet type, 2017 - 2030 (USD Million)
      • 7.5.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.5.6 Mexico
      • 7.5.6.1 Market size, by platelet type, 2017 - 2030 (USD Million)
      • 7.5.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.5.7 Argentina
      • 7.5.7.1 Market size, by platelet type, 2017 - 2030 (USD Million)
      • 7.5.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.5.7.3 Market size, by end-use, 2017 - 2030 (USD Million)
  • 7.6 Middle East & Africa
    • 7.6.1 Market size, by country, 2017 - 2030 (USD Million)
    • 7.6.2 Market size, by platelet type, 2017 - 2030 (USD Million)
    • 7.6.3 Market size, by application, 2017 - 2030 (USD Million)
    • 7.6.4 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.6.5 South Africa
      • 7.6.5.1 Market size, by platelet type, 2017 - 2030 (USD Million)
      • 7.6.5.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.5.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.6.6 Saudi Arabia
      • 7.6.6.1 Market size, by platelet type, 2017 - 2030 (USD Million)
      • 7.6.6.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.6.3 Market size, by end-use, 2017 - 2030 (USD Million)
    • 7.6.7 UAE
      • 7.6.7.1 Market size, by platelet type, 2017 - 2030 (USD Million)
      • 7.6.7.2 Market size, by application, 2017 - 2030 (USD Million)
      • 7.6.7.3 Market size, by end-use, 2017 - 2030 (USD Million)

Chapter 8 Company Profiles

  • 8.1 Startegy dashboard, 2021
  • 8.2 America's Blood Centers
    • 8.2.1 Business Overview
    • 8.2.2 Financial Data
    • 8.2.3 Product Landscape
    • 8.2.4 Strategic Outlook
    • 8.2.5 SWOT Analysis
  • 8.3 The American National Red Cross
    • 8.3.1 Business Overview
    • 8.3.2 Financial Data
    • 8.3.3 Product Landscape
    • 8.3.4 Strategic Outlook
    • 8.3.5 SWOT Analysis
  • 8.4 American Association of Blood Banks (AABB)
    • 8.4.1 Business Overview
    • 8.4.2 Financial Data
    • 8.4.3 Product Landscape
    • 8.4.4 Strategic Outlook
    • 8.4.5 SWOT Analysis
  • 8.5 Blood Centers of America
    • 8.5.1 Business Overview
    • 8.5.2 Financial Data
    • 8.5.3 Product Landscape
    • 8.5.4 Strategic Outlook
    • 8.5.5 SWOT Analysis
  • 8.6 Brazilian Red Cross
    • 8.6.1 Business Overview
    • 8.6.2 Financial Data
    • 8.6.3 Product Landscape
    • 8.6.4 Strategic Outlook
    • 8.6.5 SWOT Analysis
  • 8.7 Canadian Blood Services
    • 8.7.1 Business Overview
    • 8.7.2 Financial Data
    • 8.7.3 Product Landscape
    • 8.7.4 Strategic Outlook
    • 8.7.5 SWOT Analysis
  • 8.8 The European Blood Alliance
    • 8.8.1 Business Overview
    • 8.8.2 Financial Data
    • 8.8.3 Product Landscape
    • 8.8.4 Strategic Outlook
    • 8.8.5 SWOT Analysis
  • 8.9 French Red Cross
    • 8.9.1 Business Overview
    • 8.9.2 Financial Data
    • 8.9.3 Product Landscape
    • 8.9.4 Strategic Outlook
    • 8.9.5 SWOT Analysis
  • 8.10 German Red Cross
    • 8.10.1 Business Overview
    • 8.10.2 Financial Data
    • 8.10.3 Product Landscape
    • 8.10.4 Strategic Outlook
    • 8.10.5 SWOT Analysis
  • 8.11 Indian Red Cross Society
    • 8.11.1 Business Overview
    • 8.11.2 Financial Data
    • 8.11.3 Product Landscape
    • 8.11.4 Strategic Outlook
    • 8.11.5 SWOT Analysis
  • 8.12 Italian Red Cross
    • 8.12.1 Business Overview
    • 8.12.2 Financial Data
    • 8.12.3 Product Landscape
    • 8.12.4 Strategic Outlook
    • 8.12.5 SWOT Analysis
  • 8.13 Japanese Red Cross
    • 8.13.1 Business Overview
    • 8.13.2 Financial Data
    • 8.13.3 Product Landscape
    • 8.13.4 Strategic Outlook
    • 8.13.5 SWOT Analysis
  • 8.14 Red Cross Society of China
    • 8.14.1 Business Overview
    • 8.14.2 Financial Data
    • 8.14.3 Product Landscape
    • 8.14.4 Strategic Outlook
    • 8.14.5 SWOT Analysis
  • 8.15 OneBlood
    • 8.15.1 Business Overview
    • 8.15.2 Financial Data
    • 8.15.3 Product Landscape
    • 8.15.4 Strategic Outlook
    • 8.15.5 SWOT Analysis
  • 8.16 South African Red Cross Society
    • 8.16.1 Business Overview
    • 8.16.2 Financial Data
    • 8.16.3 Product Landscape
    • 8.16.4 Strategic Outlook
    • 8.16.5 SWOT Analysis
  • 8.17 Spanish Red Cross
    • 8.17.1 Business Overview
    • 8.17.2 Financial Data
    • 8.17.3 Product Landscape
    • 8.17.4 Strategic Outlook
    • 8.17.5 SWOT Analysis

Data Tables

  • TABLE 1 Global blood platelets market, 2017 - 2021 (USD Million)
  • TABLE 2 Global blood platelets market, 2022 - 2030 (USD Million)
  • TABLE 3 Global blood platelets market, by platelet type, 2017 - 2021 (USD Million)
  • TABLE 4 Global blood platelets market, by platelet type, 2022 - 2030 (USD Million)
  • TABLE 5 Global Blood platelets market, by application, 2017 - 2021 (USD Million)
  • TABLE 6 Global blood platelets market, by application, 2022 - 2030 (USD Million)
  • TABLE 7 Global blood platelets market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 8 Global blood platelets market, by end-use, 2022 - 2030 (USD Million)
  • TABLE 9 Global blood platelets market, by region, 2017 - 2021 (USD Million)
  • TABLE 10 Global blood platelets market, by region, 2022 - 2030 (USD Million)
  • TABLE 11 Industry impact forces
  • TABLE 12 North America, by country, 2017 - 2030 (USD)
  • TABLE 13 North America, by country, 2022 - 2030 (USD)
  • TABLE 14 U.S., by platelet type, 2017 - 2030 (USD)
  • TABLE 15 U.S., by platelet type, 2022 - 2030 (USD)
  • TABLE 16 Canada, by platelet type, 2017 - 2030 (USD)
  • TABLE 17 Canada, by platelet type, 2022 - 2030 (USD)
  • TABLE 18 Europe, by country, 2017 - 2030 (USD)
  • TABLE 19 Europe, by country, 2022 - 2030 (USD)
  • TABLE 20 Germany, by platelet type, 2017 - 2030 (USD)
  • TABLE 21 Germany, by platelet type, 2022 - 2030 (USD)
  • TABLE 22 UK, by platelet type, 2017 - 2030 (USD)
  • TABLE 23 UK, by platelet type, 2022 - 2030 (USD)
  • TABLE 24 France, by platelet type, 2017 - 2030 (USD)
  • TABLE 25 France, by platelet type, 2022 - 2030 (USD)
  • TABLE 26 Spain, by platelet type, 2017 - 2030 (USD)
  • TABLE 27 Spain, by platelet type, 2022 - 2030 (USD)
  • TABLE 28 Italy, by platelet type, 2017 - 2030 (USD)
  • TABLE 29 Italy, by platelet type, 2022 - 2030 (USD)
  • TABLE 30 Asia Pacific, by country, 2017 - 2030 (USD)
  • TABLE 31 Asia Pacific, by country, 2022 - 2030 (USD)
  • TABLE 32 China, by platelet type, 2017 - 2030 (USD)
  • TABLE 33 China, by platelet type, 2022 - 2030 (USD)
  • TABLE 34 Japan, by platelet type, 2017 - 2030 (USD)
  • TABLE 35 Japan, by platelet type, 2022 - 2030 (USD)
  • TABLE 36 India, by platelet type, 2017 - 2030 (USD)
  • TABLE 37 India, by platelet type, 2022 - 2030 (USD)
  • TABLE 38 Australia, by platelet type, 2017 - 2030 (USD)
  • TABLE 39 Australia, by platelet type, 2022 - 2030 (USD)
  • TABLE 40 South Korea, by platelet type, 2017 - 2030 (USD)
  • TABLE 41 South Korea, by platelet type, 2022 - 2030 (USD)
  • TABLE 42 Latin America, by country, 2017 - 2030 (USD)
  • TABLE 43 Latin America, by country, 2022 - 2030 (USD)
  • TABLE 44 Brazil, by platelet type, 2017 - 2030 (USD)
  • TABLE 45 Brazil, by platelet type, 2022 - 2030 (USD)
  • TABLE 46 Mexico, by platelet type, 2017 - 2030 (USD)
  • TABLE 47 Mexico, by platelet type, 2022 - 2030 (USD)
  • TABLE 48 Argentina, by platelet type, 2017 - 2030 (USD)
  • TABLE 49 Argentina, by platelet type, 2022 - 2030 (USD)
  • TABLE 50 MEA, by country, 2017 - 2030 (USD)
  • TABLE 51 MEA, by country, 2022 - 2030 (USD)
  • TABLE 52 South Africa, by platelet type, 2017 - 2030 (USD)
  • TABLE 53 South Africa, by platelet type, 2022 - 2030 (USD)
  • TABLE 54 Saudi Arabia, by platelet type, 2017 - 2030 (USD)
  • TABLE 55 Saudi Arabia, by platelet type, 2022 - 2030 (USD)
  • TABLE 56 UAE, by platelet type, 2017 - 2030 (USD)
  • TABLE 57 UAE, by platelet type, 2022 - 2030 (USD)
  • TABLE 58 Whole blood derived platelets market, by region, 2017 - 2021 (USD Million)
  • TABLE 59 Whole blood derived platelets market, by region, 2022 - 2030 (USD Million)
  • TABLE 60 Apheresis derived platelets market, by region, 2017 - 2021, (USD Million)
  • TABLE 61 Apheresis derived platelets market, by region, 2022 - 2030, (USD Million)
  • TABLE 62 Hemophilia market, by region, 2017 - 2021, (USD Million)
  • TABLE 63 Hemophilia market, by region, 2022 - 2030, (USD Million)
  • TABLE 64 Thrombocytopenia market, by region, 2017 - 2021, (USD Million)
  • TABLE 65 Thrombocytopenia market, by region, 2022 - 2030, (USD Million)
  • TABLE 66 Perioperative indications market, by region, 2017 - 2021, (USD Million)
  • TABLE 67 Perioperative indications market, by region, 2022 - 2030, (USD Million)
  • TABLE 68 Platelet function disorders market, by region, 2017 - 2021, (USD Million)
  • TABLE 69 Platelet function disorders market, by region, 2022 - 2030, (USD Million)
  • TABLE 70 Hemato-oncology market, by region, 2017 - 2021, (USD Million)
  • TABLE 71 Hemato-oncology market, by region, 2022 - 2030, (USD Million)
  • TABLE 72 Others market, by region, 2017 - 2021, (USD Million)
  • TABLE 73 Others market, by region, 2022 - 2030, (USD Million)
  • TABLE 74 Hospitals market, by region, 2017 - 2021, (USD Million)
  • TABLE 75 Hospitals market, by region, 2022 - 2030, (USD Million)
  • TABLE 76 Ambulatory surgical centers market, by region, 2017 - 2021, (USD Million)
  • TABLE 77 Ambulatory surgical centers market, by region, 2022 - 2030, (USD Million)
  • TABLE 78 Others market, by region, 2017 - 2021, (USD Million)
  • TABLE 79 Others market, by region, 2022 - 2030, (USD Million)
  • TABLE 80 North America blood platelets market, by country, 2017-2021, (USD Million)
  • TABLE 81 North America blood platelets market, by country, 2022-2030, (USD Million)
  • TABLE 82 North America blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 83 North America blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 84 North America blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 85 North America blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 86 North America blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 87 North America blood platelets market, by product, 2022-2030, (USD Million)
  • TABLE 88 U.S. blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 89 U.S. blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 90 U.S. blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 91 U.S. blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 92 U.S. blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 93 U.S. blood platelets market, by end-use, 2022-2030, (USD Million)
  • TABLE 94 Canada blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 95 Canada blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 96 Canada blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 97 Canada blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 98 Canada blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 99 Canada blood platelets market, by end-use, 2022-2030, (USD Million)
  • TABLE 100 Europe Blood platelets market, by country, 2017-2021, (USD Million)
  • TABLE 101 Europe Blood platelets market, by country, 2022-2030, (USD Million)
  • TABLE 102 Europe blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 103 Europe blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 104 Europe blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 105 Europe blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 106 Europe blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 107 Europe blood platelets market, by product, 2022-2030, (USD Million)
  • TABLE 108 Germany blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 109 Germany blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 110 Germany blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 111 Germany blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 112 Germany blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 113 Germany blood platelets market, by end-use, 2022-2030, (USD Million)
  • TABLE 114 UK blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 115 UK blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 116 UK blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 117 UK blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 118 UK blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 119 UK blood platelets market, by end-use, 2022-2030, (USD Million)
  • TABLE 120 France blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 121 France blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 122 France blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 123 France blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 124 France blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 125 France blood platelets market, by end-use, 2022-2030, (USD Million)
  • TABLE 126 Spain blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 127 Spain blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 128 Spain blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 129 Spain blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 130 Spain blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 131 Spain blood platelets market, by end-use, 2022-2030, (USD Million)
  • TABLE 132 Italy blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 133 Italy blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 134 Italy blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 135 Italy blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 136 Italy blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 137 Italy blood platelets market, by end-use, 2022-2030, (USD Million)
  • TABLE 138 Asia Pacific Blood platelets market, by country, 2017-2021, (USD Million)
  • TABLE 139 Asia Pacific Blood platelets market, by country, 2022-2030, (USD Million)
  • TABLE 140 Asia Pacific blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 141 Asia Pacific blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 142 Asia Pacific blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 143 Asia Pacific blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 144 Asia Pacific blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 145 Asia Pacific blood platelets market, by product, 2022-2030, (USD Million)
  • TABLE 146 China blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 147 China blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 148 China blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 149 China blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 150 China blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 151 China blood platelets market, by end-use, 2022-2030, (USD Million)
  • TABLE 152 Japan blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 153 Japan blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 154 Japan blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 155 Japan blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 156 Japan blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 157 Japan blood platelets market, by end-use, 2022-2030, (USD Million)
  • TABLE 158 India blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 159 India blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 160 India blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 161 India blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 162 India blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 163 India blood platelets market, by end-use, 2022-2030, (USD Million)
  • TABLE 164 Australia blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 165 Australia blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 166 Australia blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 167 Australia blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 168 Australia blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 169 Australia blood platelets market, by end-use, 2022-2030, (USD Million)
  • TABLE 170 South Korea blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 171 South Korea blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 172 South Korea blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 173 South Korea blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 174 South Korea blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 175 South Korea blood platelets market, by end-use, 2022-2030, (USD Million)
  • TABLE 176 Latin America Blood platelets market, by country, 2017-2021, (USD Million)
  • TABLE 177 Latin America Blood platelets market, by country, 2022-2030, (USD Million)
  • TABLE 178 Latin America blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 179 Latin America blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 180 Latin America blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 181 Latin America blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 182 Latin America blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 183 Latin America blood platelets market, by product, 2022-2030, (USD Million)
  • TABLE 184 Brazil blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 185 Brazil blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 186 Brazil blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 187 Brazil blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 188 Brazil blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 189 Brazil blood platelets market, by end-use, 2022-2030, (USD Million)
  • TABLE 190 Mexico blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 191 Mexico blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 192 Mexico blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 193 Mexico blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 194 Mexico blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 195 Mexico blood platelets market, by end-use, 2022-2030, (USD Million)
  • TABLE 196 Argentina blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 197 Argentina blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 198 Argentina blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 199 Argentina blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 200 Argentina blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 201 Argentina blood platelets market, by end-use, 2022-2030, (USD Million)
  • TABLE 202 MEA Blood platelets market, by country, 2017-2021, (USD Million)
  • TABLE 203 MEA Blood platelets market, by country, 2022-2030, (USD Million)
  • TABLE 204 MEA blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 205 MEA blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 206 MEA blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 207 MEA blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 208 MEA blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 209 MEA blood platelets market, by product, 2022-2030, (USD Million)
  • TABLE 210 South Africa blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 211 South Africa blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 212 South Africa blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 213 South Africa blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 214 South Africa blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 215 South Africa blood platelets market, by end-use, 2022-2030, (USD Million)
  • TABLE 216 Saudi Arabia blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 217 Saudi Arabia blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 218 Saudi Arabia blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 219 Saudi Arabia blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 220 Saudi Arabia blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 221 Saudi Arabia blood platelets market, by end-use, 2022-2030, (USD Million)
  • TABLE 222 UAE blood platelets market, by platelet type, 2017-2021, (USD Million)
  • TABLE 223 UAE blood platelets market, by platelet type, 2022-2030, (USD Million)
  • TABLE 224 UAE blood platelets market, by application, 2017-2021, (USD Million)
  • TABLE 225 UAE blood platelets market, by application, 2022-2030, (USD Million)
  • TABLE 226 UAE blood platelets market, by end-use, 2017-2021, (USD Million)
  • TABLE 227 UAE blood platelets market, by end-use, 2022-2030, (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach
  • FIG. 2 Breakdown of primary participants
  • FIG. 3 Blood platelets industry 360 degree synopsis, 2017 - 2030
  • FIG. 4 Industry segmentation
  • FIG. 5 Global blood platelets market, 2017 - 2030 (USD Million)
  • FIG. 6 Growth potential analysis, by platelet type
  • FIG. 7 Growth potential analysis, by application
  • FIG. 8 Growth potential analysis, by end-use
  • FIG. 9 Gap analysis
  • FIG. 10 Porter's Analysis
  • FIG. 11 Company matrix analysis, 2021
  • FIG. 12 PESTEL Analysis
  • FIG. 13 Key segment trends, by platelet type
  • FIG. 14 Key segment trends, by application
  • FIG. 15 Key segment trends, by end-use
  • FIG. 16 Key regional trends
  • FIG. 17 Strategy dashboard, 2021